key: cord-0908564-g52ouz0u
authors: Du, Fangzhi; Zhang, Ruili; Wang, Qianqiu
title: Eliminating Mother-to-Child Transmission of Syphilis: Chinese Practice before and during COVID-19 Pandemics
date: 2022-03-31
journal: Chinese Medical Sciences Journal
DOI: 10.24920/003903
sha: ae50ab0bda641e2d012efdf7f867fafb471e5130
doc_id: 908564
cord_uid: g52ouz0u

Mother-to-child transmission (MTCT) of syphilis remains a leading cause of stillbirth and death among neonates in many developing countries. In 2007, World Health Orgernization launched the global elimination of MTCT (EMTCT) of syphilis. Given the high burden of congenital syphilis, China subsequently released the specific national EMTCT policies and programs to reduce MTCT of syphilis. The congenital syphilis incidence rate per 100,000 live births in China has markedly decreased from 69.9 in 2013 to 11.9 in 2019. However, due to the global pandemic of COVID-19, the current measures for eliminating MTCT of syphilis are greatly challenged. In this article, we summarize the strategies and measures for the EMTCT of syphilis in China in the past 20 years, the remarkable achievements by the policy support under the leadership of the government. In the context of COVID-19 pandemics, strengthening emergency response to the regional outbreaks of COVID-19, adopting safe, rapid, early and high-quality clinical care for 100% of pregnant women to receive prenatal syphilis testing services, ensuring the availability of Benzathine penicillin for the treatment, and strengthening the closed-loop management of pregnant women and newborns infected with syphilis are the key measures to determine the effectiveness of MTCT for syphilis. Lessons from China may be valuable for other countries that are planning to eliminate MTCT of syphilis.

The adverse outcomes of pregnant women with syphilis present as stillbirth, early fetal death, low birth weight, preterm delivery, neonatal death, infection or disease in newborns [1, 2] . In 2016, the World Health Organization (WHO) estimated that annually, about 930,000 pregnant women suffer from active syphilis worldwide, resulting in approximately 350,000 adverse birth outcomes, over half of which are neonatal death and stillbirth [3] . Mother-to-child transmission (MTCT) of syphilis, commonly called as "congenital syphilis", remains a leading cause of stillbirth and death of neonates in many developing countries. Studies have and/or syphilis [5] . Evidences from these countries or regions are of great help to countries in which syphilis is preventable with basic public health activities. However, it remains difficult to eliminate MTCT for many countries worldwide, particularly countries with high burden of maternal syphilis or with high infection rate of syphilis among high-risk populations.

China is one of the countries with high disease burden of syphilis. The number of congenital syphilis cases in China has increased from 468 in 2000 to 10 ,032 in 2013, the corresponding incidence increased from 2.6 per 100,000 live births in 2000 to 69.9 in 2013, which was nearly 26-fold higher [6] . Facing such a high burden of congenital syphilis, China released national policies and programmes specifically on EMTCT of syphilis. In 2016, it was reported that the congenital syphilis cases in China was 29.8 per 100,000 live births, the population-level antenatal care coverage reached 99%, and HIV and/or syphilis testing cover 99% of pregnant women [7] , which well met the WHO standard for elimination. Based on these achieve- 11 .87 per 100,000 live births [8] .

The MOH of China launched a pilot project on the prevention of MTCT (PMTCT) in eight counties (cities, districts) of five provinces (regions) in 2002 [9] . In the next year, MOH issued the National Working Guidelines to Prevent Mother-to-Child Transmission of HIV [9] . In 2006, the provision of PMTCT of HIV services was ratified by the AIDS Prevention and Control Regulations, which was announced by the State Council of the People's Republic of China. Subsequently, the health care services were initially provided to all pregnant women with HIV/syphilis/hepatitis B who attended the national sentinel sites [10] . Based on the experiences from PMTCT of HIV program, as well as the high burden of maternal syphilis, the MOH issued the China 2010-2020 Plan for Syphilis Control and Prevention in June 2010 [11] . This plan set an overall target to reduce the incidence of MTCT of syphilis through dual control, which included keeping MTCT of HIV below 15 per 100,000 live births by 2020, setting several stepwise but ambitious benchmarks for antenatal syphilis screening coverage (80% by 2015 and 90% by 2020) and intervention uptake rates (90% by 2015 and 95% by 2020) among infected mothers and their infants. In 2011, the MOH further issued a national policy specifically aiming at integrating preventive measures for MTCT of HIV, syphilis and hepatitis B, which was implemented as the core strategies for syphilis control in China in the following years [12] . Since 2015, the screening of antenatal HIV/ syphilis/hepatitis B and the treatment of HIV/syphilis have covered all pregnant women and their infants throughout the country.

In China, service network of women and children's health (WCH) has been gradually formed, which is composed of general hospitals, WCH institutions, and community-based healthcare services at multiple levels, e.g., province, district, county, township, and village. At the end of 2018, there were 3,080 WCH institutions, 807 maternity hospitals, and 129 children's hospitals nationwide, playing a core role in EMTCT of HIV and syphilis [9] . Health professionals from the WCH services network in China provide specialized all-round preventive and curative care. These services include premarital health care, prenatal and postnatal care, reproductive healthcare, neonatal care, infants care, and preschool children care [11] . Referral system for syphilis 

While China has made significant achievements in EMTCT of syphilis, there remains a gap to full success of EMTCT of syphilis.

Firstly, despite the high coverage of antenatal care and syphilis testing in pregnant Chinese women, it is estimated that only 80% of pregnant women with positive test of syphilis receive proper treatment, and only 53% complete recommended treatment for syphilis during pregnancy [14] . The main reason is that many pregnant women start to receive antenatal care in the last trimester, which is too late to receive two-course anti-syphilis therapy, because the time interval of twocourse treatment is at least four weeks. In response, the current Chinese Syphilis Treatment Guidelines recommend one-course treatment with three injections of benzathine penicillin G to infected pregnant women, disregarding their syphilis stages, with exception of neurosyphilis or cardiovascular syphilis [15] . However, pregnant women of floating population who are not registered in local household registration system and people in remote area of China do not have full access to these care services, which needs to be improved in future.

Secondly, China maintains large number of newly reported syphilis case each year; for instance, a total of 587,404 new cases were reported in 2019 [16] . The high prevalence of syphilis, particularly among the high-risk populations, leads to a high incidence of maternal syphilis, and hence a high incidence of congenital syphilis [17] . For EMTCT of syphilis, effective control exceeded 420 million [18] . With the rapid spread of COVID-19 around the world, the global healthcare sector faces huge challenges on prevention and control of sexually transmitted diseases. A few months after the outbreak of COVID-19, many countries enact strict prevention measures, such as social distancing, stayat-home order, banning entertainment activities, closing nonessential businesses, etc [19] [20] [21] [22] . Meantime, many health care clinics either close or limit in-person visits to symptomatic cases, and accesses to STD intervention services are limited as well. Screenings and hospital visits reduced, treatment and follow-up services postponed, which results in a significant decrease in the incidence of new reported syphilis [23, 24] .

In the early months after the outbreak of for syphilis patients and their sexual partners [23] . On the other hand, novel coronavirus infection has been reported causing transient immunodeficiency, with potentially harmful immunological and clinical consequences [25] , which may change the course of syphilis and affect the therapeutic effect.

In view of long-lasting COVID-19 pandemic, it is necessary to make an emergency preparedness to ensure timely response regarding EMTCT of syphilis when regional outbreak occurs. The measures may include: [26] .

In addition, follow-up of infants born to syphilis infected mother is always a great challenge, and COVID-19 epidemics may make the situation worse.

Therefore, management of infants born to syphilis infected mother should be undertake by receiving hospital at a one-on-one base and followed up regularly to achieve a closed-loop management of diagnosis and treatment. Moreover, pregnant women also need to strengthen protection to reduce the infection risk of COVID-19.

The remarkable achievements in EMTCT of syphilis in China illustrate the importance of strong leadership and policy support of the government, as well as the crucial role of a high coverage of antenatal care and a well-organized monitoring and surveillance

Global estimates of syphilis in pregnancy and associated adverse outcomes: analysis of multinational antenatal surveillance data

Surveillance of maternal syphilis in China: pregnancy outcomes and determinants of congenital syphilis

Global burden of maternal land congenital syphilis in 2008 and 2012: a health systems modelling study

The global elimination of congenital syphilis: rationale and strategy for action

World Health Organization. Global Sexually Transmitted Infections Programme. Mother-to-child transmission of syphilis

Meta-analysis of effect of prevention of mother to child transmission of HIV during 2011-2014 in China

Prevention of mother-to-child transmission of syphilis: technical measures and effectiveness

Trends and epidemiologic features of syphilis in China

People's Republic of China. Report on women and children's health development in China

Evolution of China's response to HIV/AIDS

Embassy of the People's Republic of China in the United State of America. The State Council Information Office of the People's Republic of China. Government white papers: medical and health services in China

Circulating microRNAs as potential biomarkers in the diagnosis of neurosyphilis

The State Council Information Office of the People's Republic of China. Medical and health services in China: white paper

Treatment evaluation to improve preventing mother to child transmission among women with syphilis

Chinese Society of Dermatology; Subcommittee on Venereology, China Dermatologist Association. Guidelines for the diagnosis and treatment of syphilis, gonorrhea, and genital chlamydial infection

Bureau of Disease Prevention and Control, National Health Commission of the People's Republic of China. National overview of statutory infectious disease outbreaks in 2019

Turning off the tap: sustaining elimination of congenital syphilis through the programme targeting high-risk groups

World Hearlth Orgernization. Coronavirus disease (COVID-19) pandemic

Timing of state and territorial COVID-19 stay-at-home orders and changes in population movement: United States

Public attitudes, behaviors, and beliefs related to COVID-19, stay-at-home orders, nonessential business closures, and public health guidance-United States

Guidance for businesses and employers responding to coronavirus disease 2019 (COVID-19)

Declaring a National Emergency Concerning the Novel Coronavirus Disease (COVID-19) Outbreak

Trends in nationally notifiable sexually transmitted disease case reports during the US COVID-19 pandemic

The impact of the COVID-19 pandemic on Sexually Transmitted Infections surveillance data: incidence drop or artefact?

COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients

A preparedness model for mother-baby linked longitudinal surveillance for emerging threats